These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 13863224)

  • 21. [Electromyography as a method of studies on physiological properties of the motor apparatus in paralysis following poliomyelitis].
    KISELEV PA; NIKOLAEV VI; REGO SI; UFLIAND IuM; FRIDMAN SIa
    Tr Leningr Sanitarnogig Med Inst; 1956; 29():176-96. PubMed ID: 13455754
    [No Abstract]   [Full Text] [Related]  

  • 22. [STUDIES ON THE TOLERANCE AND EFFICACY OF LIVE POLIOMYELITIS VIRUS VACCINE TYPE I].
    HENNESSEN W; ALTEVOGT R; MAULER R; LANGE A; BOEHM R
    Dtsch Med Wochenschr; 1963 Dec; 88():2387-90. PubMed ID: 14163000
    [No Abstract]   [Full Text] [Related]  

  • 23. The relation between acute persisting spinal paralysis and poliomyelitis vaccine (oral): results of a WHO enquiry.
    Bull World Health Organ; 1976; 53(4):319-31. PubMed ID: 1086727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relation of symptoms to the pathological physiology in poliomyelitis.
    GUYTON AC
    J Tn State Med Assoc; 1948 Jul; 41(7):254-8. PubMed ID: 18871937
    [No Abstract]   [Full Text] [Related]  

  • 25. [Oral vaccines against poliomyelitis and vaccination-related paralytic poliomyelitis in Germany. Do we need a new immunization strategy?].
    Fescharek R; Arras-Reiter C; Arens ER; Quast U; Maass G
    Wien Med Wochenschr; 1997; 147(19-20):456-61. PubMed ID: 9471843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [PSYCHIATRIC OBSERVATIONS FOLLOWING POLIOMYELITIS VACCINATION].
    BECHTEL J
    Med Klin; 1964 Feb; 59():263-4. PubMed ID: 14135758
    [No Abstract]   [Full Text] [Related]  

  • 27. Poliomyelitis; effect of Salk vaccine on severity of paralysis.
    WYMAN MG; LINDGREN WD; MAGOFFIN R
    Calif Med; 1957 Jul; 87(1):1-8. PubMed ID: 13446735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nerve regeneration in poliomyelitis.
    ALLBROOK DB
    East Afr Med J; 1955 Jun; 32(6):209-13. PubMed ID: 13251146
    [No Abstract]   [Full Text] [Related]  

  • 29. [Infantile paralysis; etiology, pathogenesis, epidemiology, prophylaxis and immunity].
    CORDEIRO FERREIRA
    Bol Inst Super Hig Doutor Ricardo Jorge; 1948; 3(13):230-46. PubMed ID: 18116727
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of lumbar puncture on the course of poliomyelitis anterior acute].
    PROCHAZKA J; ADAM E; ADAMOVA V; BENDOVA N
    Prakt Lek; 1955 Jul; 35(14):313-5. PubMed ID: 13254600
    [No Abstract]   [Full Text] [Related]  

  • 31. Contributions to the study of nerve and muscle interrelationship; studies in the pathologic physiology of poliomyelitis.
    RUSKIN SL; WILEY BC
    Int Rec Med Gen Pract Clin; 1956 May; 169(5):274-9. PubMed ID: 13318739
    [No Abstract]   [Full Text] [Related]  

  • 32. [Features of disorders in conductivity of nervous impulses in the system of nerves-synapses-muscles in patients with poliomyelitis].
    MANOVICH ZKh
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1962; 62():988-92. PubMed ID: 14469412
    [No Abstract]   [Full Text] [Related]  

  • 33. [A vaccine against poliomyelitis--its production and requirements (live and killed vaccines)].
    GAON J
    Med Arh; 1960; 14():1-9. PubMed ID: 13826342
    [No Abstract]   [Full Text] [Related]  

  • 34. On respiratory regulation in poliomyelitis convalescents.
    LINDERHOLM H; WERNEMAN H
    Acta Med Scand Suppl; 1956; 316():135-57. PubMed ID: 13354291
    [No Abstract]   [Full Text] [Related]  

  • 35. Eradication of poliomyelitis--present status and future prospects.
    SABIN AB
    R I Med J; 1962 Sep; 45():453-62. PubMed ID: 14495783
    [No Abstract]   [Full Text] [Related]  

  • 36. [ANTIBODY FORMATION AFTER 3 DOSES OF QUADRUPLE VACCINE INJECTION FOLLOWED BY TRIVALENT ORAL POLIOMYELITIS VACCINE].
    HENIGST W; MUELLER F
    Dtsch Med Wochenschr; 1965 Aug; 90():1502-6. PubMed ID: 14344415
    [No Abstract]   [Full Text] [Related]  

  • 37. REQUIREMENTS for biological substances. 1. General requirements for manufacturing establishments and control laboratories. 2. Requirements for poliomyelitis vaccine (inactivated). Report of a study group.
    World Health Organ Tech Rep Ser; 1959; 178():1-30. PubMed ID: 13858460
    [No Abstract]   [Full Text] [Related]  

  • 38. [Gastric acidity in poliomyelitis patients].
    TOSI HC; SANGUINETTI CM
    An Fac Med Univ Repub Montev Urug; 1959; 44():560-5. PubMed ID: 13838992
    [No Abstract]   [Full Text] [Related]  

  • 39. [USE OF HOMOTYPE ORAL ANTIPOLIOMYELITIC VACCINE DURING AN EPIDEMIC OCCURRING IN FRANCE AND DUE TO TYPE I POLIOMYELITIS VIRUS].
    DEBRE R; COULON G; LEDOURNEUF G; GAUTIER M; CELERS J; DROUHET V; BOUE A
    Bull Acad Natl Med; 1964 Feb 4-11; 148():75-86. PubMed ID: 14136499
    [No Abstract]   [Full Text] [Related]  

  • 40. [Study of respiratory function and thoracic kinematics in a chronic anterior poliomyelitis patient].
    DEREUX J; CRINQUETTE J
    J Sci Med Lille; 1955; 73(8-9):364-70. PubMed ID: 13286765
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.